The Cefadroxil Capsules, cataloged under National Stock Number 6505-01-244-0211, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Bristol-Myers Co. Government technical data includes 4 specifications, cited from the U.S. Government catalog. The record lists 3 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 4 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-244-0211 |
| Primary Part Number | NDC59772-7271-03 |
| Item Name | Cefadroxil Capsules |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Bristol-Myers Co |
| Status | ACTIVE |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Capsule Primary Container Content Quantity | 50.000 |
| Active Medicament Medicinal Strength | 500.000 MILLIGRAMS CEFADROXIL ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC59772-7271-03 | Bristol-Myers Co (USA) |
| NDC59772-7271-30 | Bristol-Myers Co (USA) |
| NDC00172-4058-48 | Zenith Laboratories Inc (USA) |
| Reference | Meaning |
|---|---|
| NDC00087-0784-46 | 5/9 Secondary reference Bristol-Myers Squibb Company Dba Bristol-Myers Squibb |
| NDC00087-0784-46 | 3/9 Design control — primary reference Bristol-Myers Squibb Pharmaceutical Group Squibb Us Pharmaceutical Div |
| DURICEF | 5/9 Secondary reference Bristol-Myers Squibb Pharmaceutical Group Squibb Us Pharmaceutical Div |
| ULTRACEF | 5/1 Secondary reference Mead Johnson & Company, Llc |
NSN 6505-01-244-0211 is a Cefadroxil Capsules, manufactured by Bristol-Myers Co, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-244-0211 has 3 manufacturer part numbers on file: NDC59772-7271-03 (Bristol-Myers Co), NDC59772-7271-30 (Bristol-Myers Co), NDC00172-4058-48 (Zenith Laboratories Inc).
Key specifications for NDC59772-7271-03: Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE; Capsule Primary Container Content Quantity: 50.000; Part Name Assigned by Controlling Agency: CEFADROXIL CAPSULES USP 500MG 50S BT. 4 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.